Effects of morphine on immune response in rats with sciatic constriction injury

被引:37
作者
Tsai, YC
Won, SJ
Lin, MT
机构
[1] Natl Cheng Kung Univ, Coll Med, Pain Management Sect, Dept Anesthesiol, Tainan 704, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan
[3] Natl Yang Ming Univ, Sch Med & Life Sci, Dept Physiol, Taipei 112, Taiwan
关键词
opioid; morphine; natural killer cell activity; splenocyte proliferation; immunity; chronic constriction injury; neuropathic pain;
D O I
10.1016/S0304-3959(00)00323-7
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
We investigated the effects of acute and of chronic morphine treatment on T-lymphocyte function and natural killer (NK) cell activity in rats receiving chronic constriction injury (CCI) of the sciatic nerve. T-Lymphocyte function was evaluated based on concanavalin-A (ConA)- and phytohemagglutinin (PHA)-induced splenocyte proliferation. The effects of morphine on thermal hyperalgesia were also assessed by measuring paw withdrawal latency (PWL) in rats. All of the rats that received CCI developed thermal hyperalgesia while sham-operated rats did not. Thermal hyperalgesia was dose-dependently reversed after acute (single injection) and after chronic (daily injection for 7 days) administration of morphine but persisted in saline-treated CCI rats. There was no significant difference between sham and saline-treated CCI groups in splenocyte proliferation and NK cell activity. NK cell activity and splenocyte proliferation induced by ConA and PHA were significantly suppressed by acute morphine treatment in a dose-dependent manner. The reversal of the thermal hyperalgesia persisted throughout the period of chronic morphine treatment. No tolerance to the suppression of NK cell activity and splenocyte proliferation was observed after chronic morphine treatment. These data suggest that both acute and chronic morphine treatment can cause a dose-dependent reversal of thermal hyperalgesia and inhibition of NK cell activity and splenocyte proliferation in rats with sciatic CCI, without concomitant development of tolerance. Opioid therapy for chronic neuropathic pain should be used cautiously, especially in immune-compromised cases. (C) 2000 International Association for the Study of Pain. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:155 / 160
页数:6
相关论文
共 35 条
[1]   THE EFFECT OF CONTINUOUS MORPHINE ANALGESIA ON CHRONIC THERMAL HYPERALGESIA DUE TO SCIATIC CONSTRICTION INJURY IN RATS [J].
BACKONJA, MM ;
MILETIC, G ;
MILETIC, V .
NEUROSCIENCE LETTERS, 1995, 196 (1-2) :61-64
[2]   NARCOTIC-INDUCED SUPPRESSION OF NATURAL-KILLER-CELL ACTIVITY IN VENTILATED AND NONVENTILATED RATS [J].
BEILIN, B ;
SHAVIT, Y ;
COHN, S ;
KEDAR, E .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 64 (02) :173-176
[3]   A PERIPHERAL MONONEUROPATHY IN RAT THAT PRODUCES DISORDERS OF PAIN SENSATION LIKE THOSE SEEN IN MAN [J].
BENNETT, GJ ;
XIE, YK .
PAIN, 1988, 33 (01) :87-107
[4]   SEVERE HERPESVIRUS INFECTIONS IN AN ADOLESCENT WITHOUT NATURAL-KILLER CELLS [J].
BIRON, CA ;
BYRON, KS ;
SULLIVAN, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (26) :1731-1735
[5]   IMMUNOLOGICAL DYSFUNCTION IN HEROIN-ADDICTS [J].
BROWN, SM ;
STIMMEL, B ;
TAUB, RN ;
KOCHWA, S ;
ROSEFIELD, RE .
ARCHIVES OF INTERNAL MEDICINE, 1974, 134 (06) :1001-1006
[6]  
BRYANT HU, 1988, J PHARMACOL EXP THER, V245, P913
[7]   OPIOID RESPONSIVENESS OF CANCER PAIN SYNDROMES CAUSED BY NEUROPATHIC OR NOCICEPTIVE MECHANISMS - A COMBINED ANALYSIS OF CONTROLLED, SINGLE-DOSE STUDIES [J].
CHERNY, NI ;
THALER, HT ;
FRIEDLANDERKLAR, H ;
LAPIN, J ;
FOLEY, KM ;
HOUDE, R ;
PORTENOY, RK .
NEUROLOGY, 1994, 44 (05) :857-861
[8]   IS DISEASE PROGRESSION THE MAJOR FACTOR IN MORPHINE-TOLERANCE IN CANCER PAIN TREATMENT [J].
COLLIN, E ;
POULAIN, P ;
GAUVAINPIQUARD, A ;
PETIT, G ;
PICHARDLEANDRI, E .
PAIN, 1993, 55 (03) :319-326
[9]   Prolonged treatment with transdermal fentanyl in neuropathic pain [J].
Dellemijn, PLI ;
van Duijn, H ;
Vanneste, JAL .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1998, 16 (04) :220-229
[10]   Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain [J].
Dellemijn, PLI ;
Vanneste, JAL .
LANCET, 1997, 349 (9054) :753-758